![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SLC35F6 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Slc35f6 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC35F6 mRNA | CTD | PMID:22206623 | SLC35F6 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC35F6 mRNA | CTD | PMID:23019147 and PMID:31614463 | SLC35F6 | Human | 17beta-estradiol | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of SLC35F6 mRNA | CTD | PMID:32145629 | SLC35F6 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35F6 mRNA | CTD | PMID:19684285 | SLC35F6 | Human | 2-bromohexadecanoic acid | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein] | CTD | PMID:38195004 | SLC35F6 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of SLC35F6 mRNA | CTD | PMID:30851411 | SLC35F6 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of SLC35F6 protein | CTD | PMID:34186270 | SLC35F6 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC35F6 mRNA | CTD | PMID:30047161 | SLC35F6 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SLC35F6 mRNA | CTD | PMID:22378314 | SLC35F6 | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | SLC35F6 | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of SLC35F6 mRNA | CTD | PMID:38218311 | SLC35F6 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Slc35f6 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC35F6 mRNA | CTD | PMID:34319233 | SLC35F6 | Human | bisphenol A | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC35F6 mRNA | CTD | PMID:25181051 | SLC35F6 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC35F6 protein | CTD | PMID:34186270 | SLC35F6 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLC35F6 mRNA | CTD | PMID:30903817 | SLC35F6 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC35F6 mRNA | CTD | PMID:29275510 | SLC35F6 | Human | bisphenol A | increases methylation | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of SLC35F6 gene | CTD | PMID:28505145 | SLC35F6 | Human | bisphenol AF | increases expression | EXP | | 6480464 | bisphenol AF results in increased expression of SLC35F6 protein | CTD | PMID:34186270 | SLC35F6 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of SLC35F6 protein | CTD | PMID:34186270 | SLC35F6 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of SLC35F6 protein | CTD | PMID:34186270 | SLC35F6 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein | CTD | PMID:38195004 | SLC35F6 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SLC35F6 protein | CTD | PMID:38195004 | SLC35F6 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of SLC35F6 protein | CTD | PMID:35688186 | SLC35F6 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of SLC35F6 mRNA | CTD | PMID:25979313 | SLC35F6 | Human | carbon nanotube | increases expression | ISO | Slc35f6 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | SLC35F6 | Human | cobalt dichloride | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of SLC35F6 mRNA | CTD | PMID:24386269 | SLC35F6 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SLC35F6 mRNA | CTD | PMID:19549813 | SLC35F6 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SLC35F6 mRNA | CTD | PMID:20106945 | SLC35F6 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SLC35F6 mRNA | CTD | PMID:37042841 | SLC35F6 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of SLC35F6 mRNA | CTD | PMID:28302478 | SLC35F6 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SLC35F6 | Human | endosulfan | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of SLC35F6 mRNA | CTD | PMID:29391264 | SLC35F6 | Human | fipronil | decreases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of SLC35F6 mRNA | CTD | PMID:23962444 | SLC35F6 | Human | folic acid | multiple interactions | ISO | Slc35f6 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC35F6 mRNA | CTD | PMID:22206623 | SLC35F6 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SLC35F6 protein | CTD | PMID:37730182 | SLC35F6 | Human | gentamycin | decreases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC35F6 mRNA | CTD | PMID:33387578 | SLC35F6 | Human | methimazole | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of SLC35F6 mRNA | CTD | PMID:30047161 | SLC35F6 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SLC35F6 mRNA | CTD | PMID:21420995 | SLC35F6 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC35F6 mRNA | CTD | PMID:29067470 | SLC35F6 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SLC35F6 mRNA | CTD | PMID:32588087 | SLC35F6 | Human | phenobarbital | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Phenobarbital results in increased expression of SLC35F6 mRNA | CTD | PMID:30047161 | SLC35F6 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of SLC35F6 mRNA | CTD | PMID:26272509 | SLC35F6 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F6 mRNA | CTD | PMID:27188386 | SLC35F6 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of SLC35F6 mRNA | CTD | PMID:30851411 | SLC35F6 | Human | rotenone | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of SLC35F6 mRNA | CTD | PMID:28374803 | SLC35F6 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SLC35F6 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SLC35F6 mRNA | CTD | PMID:38568856 | SLC35F6 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite promotes the reaction [SLC35F6 protein binds to CAPRIN1 protein] | CTD | PMID:33939924 | SLC35F6 | Human | sodium fluoride | decreases expression | ISO | Slc35f6 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of SLC35F6 mRNA | CTD | PMID:27862939 | SLC35F6 | Human | sulfadimethoxine | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of SLC35F6 mRNA | CTD | PMID:30047161 | SLC35F6 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of SLC35F6 mRNA | CTD | PMID:31533062 | SLC35F6 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of SLC35F6 mRNA | CTD | PMID:38568856 | SLC35F6 | Human | triptonide | affects expression | ISO | Slc35f6 (Mus musculus) | 6480464 | triptonide affects the expression of SLC35F6 mRNA | CTD | PMID:33045310 | SLC35F6 | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SLC35F6 mRNA | CTD | PMID:29024780 | SLC35F6 | Human | tungsten | increases expression | ISO | Slc35f6 (Mus musculus) | 6480464 | Tungsten results in increased expression of SLC35F6 mRNA | CTD | PMID:30912803 | SLC35F6 | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of SLC35F6 mRNA | CTD | PMID:29453283 | SLC35F6 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC35F6 mRNA | CTD | PMID:25979313 | SLC35F6 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F6 mRNA | CTD | PMID:27188386 | SLC35F6 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC35F6 mRNA | CTD | PMID:23179753 more ... | SLC35F6 | Human | vinclozolin | increases expression | ISO | Slc35f6 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SLC35F6 mRNA | CTD | PMID:22570695 | |